MPS VI Recruiting Phase 1 Trials for Laronidase (DB00090)

IndicationStatusPhase
DBCOND0053627 (MPS VI)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04532047
In Utero Enzyme Replacement Therapy for Lysosomal Storage DiseasesTreatment